Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2016-09-16 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: HAGETMAU (40700), Landes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CENTRALE D'HAGETMAU : revenue, balance sheet and financial ratios
PHARMACIE CENTRALE D'HAGETMAU is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in HAGETMAU (40700),
this company of category PME
shows in 2025 a net income positive of 171 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CENTRALE D'HAGETMAU (SIREN 822554127)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
170 690 €
116 087 €
158 125 €
423 566 €
329 178 €
253 759 €
85 881 €
246 970 €
264 627 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE CENTRALE D'HAGETMAU generates positive net income of 171 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 265 k€ -> 171 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
170 690 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 53%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
53.446%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
58.391%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CENTRALE D'HAGETMAU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
671.618
382.652
329.685
187.569
144.407
99.649
86.227
69.271
53.446
Financial autonomy
11.258
18.283
20.316
30.918
37.152
44.674
49.221
52.916
58.391
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
53.452025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
In 2025, the debt ratio of PHARMACIE CENTRALE D'HAGE... (53.45) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
58.39%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+6 pts over 3 years
In 2025, the financial autonomy of PHARMACIE CENTRALE D'HAGE... (58.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 179.05. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
179.053
Liquidity indicators evolution PHARMACIE CENTRALE D'HAGETMAU
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
155.081
192.108
188.489
206.35
254.375
255.984
234.895
184.728
179.053
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
179.052025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average-16 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE CENTRALE D'HAGE... (179.05) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE CENTRALE D'HAGETMAU in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE CENTRALE D'HAGETMAU is estimated at
2 711 430 €
(range 1 839 989€ - 4 254 608€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1839k€2711k€4254k€
2 711 430 €Range: 1 839 989€ - 4 254 608€
NAF 5 année 2025
Valuation method used
Net Income Multiple
170 690 €
×
15.9x
=2 711 431 €
Range: 1 839 990€ - 4 254 609€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CENTRALE D'HAGETMAU with other companies in the same sector:
Frequently asked questions about PHARMACIE CENTRALE D'HAGETMAU
What is the revenue of PHARMACIE CENTRALE D'HAGETMAU ?
The revenue of PHARMACIE CENTRALE D'HAGETMAU is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE CENTRALE D'HAGETMAU profitable?
Yes, PHARMACIE CENTRALE D'HAGETMAU generated a net profit of 171 k€ in 2025.
Where is the headquarters of PHARMACIE CENTRALE D'HAGETMAU ?
The headquarters of PHARMACIE CENTRALE D'HAGETMAU is located in HAGETMAU (40700), in the department Landes.
Where to find the tax return of PHARMACIE CENTRALE D'HAGETMAU ?
The tax return of PHARMACIE CENTRALE D'HAGETMAU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CENTRALE D'HAGETMAU operate?
PHARMACIE CENTRALE D'HAGETMAU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart